Biotech · Private company
K C Pharmaceuticals Inc.
Track this companyFree. Adds K C Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- Eflornithine (DFMO) and Etoposide for Relapsed/Refractory NeuroblastomaPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 25, 2020ClinicalTrials.gov NCT04301843 · fetched Nov 12, 2026
- Pediatric Precision Laboratory Advanced Neuroblastoma TherapyPHASE2 · RECRUITING · started Sep 1, 2015ClinicalTrials.gov NCT02559778 · fetched Nov 12, 2026
- Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in RemissionPHASE2 · COMPLETED · started Mar 5, 2015ClinicalTrials.gov NCT02395666 · fetched Nov 12, 2026
- Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory NeuroblastomaPHASE1_PHASE2 · COMPLETED · started Jun 6, 2014ClinicalTrials.gov NCT02139397 · fetched Nov 12, 2026
- An Intermediate Expanded Use Trial of DFMOAVAILABLEClinicalTrials.gov NCT03581240 · fetched Nov 12, 2026